Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quercetin promotes the secretion of musk by regulating the hormone level and microbial structure of forest musk deer. | Integr Zool | 2024 | 37789560 | PubTator, text mining | PubMed |
| Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort. | Brain | 2024 | 37721175 | PubTator, text mining | PubMed |
| Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome. | J Neurol | 2024 | 37682316 | PubTator, text mining | PubMed |
| Calprotectin: two sides of the same coin. | Rheumatology (Oxford) | 2024 | 37603715 | PubTator, text mining | PubMed |
| Inpatient Burden of Neurological Disorders: A Route Map for Allocation of Resources and Postgraduate Training. | Cureus | 2023 | 38288171 | PubTator, text mining | PubMed |
| Parkinson's disease and comorbid myasthenia gravis: a case report and literature review. | Front Neurol | 2023 | 38259657 | PubTator, text mining | PubMed |
| Impact of structural modifications of IgG antibodies on effector functions. | Front Immunol | 2023 | 38259472 | PubTator, text mining | PubMed |
| Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients. | Medicina (Kaunas) | 2023 | 38256317 | PubTator, text mining | PubMed |
| Have one's view of the important overshadowed by the trivial: chronic progressive external ophthalmoplegia combined with unilateral facial nerve injury: a case report and literature review. | Front Neurol | 2023 | 38249737 | PubTator, text mining | PubMed |
| Transmission-selective muscle pathology induced by the active propagation of mutant huntingtin across the human neuromuscular synapse. | Front Mol Neurosci | 2023 | 38235149 | PubTator, text mining | PubMed |
| Agenesis of Pectoralis Major Muscle in Late-Onset GFPT1-Related Congenital Myasthenic Syndrome: A Case Report. | Neurol Genet | 2023 | 38235042 | PubTator, text mining | PubMed |
| Systemic Vasculitis Presenting with Central and Peripheral Involvement. | Ann Indian Acad Neurol | 2023 | 38229635 | PubTator, text mining | PubMed |
| Anti-Muscle-Specific Kinase (MuSK) Antibody-Positive Myasthenia Gravis Presenting With Dyspnea in an Elderly Woman: A Case Report. | Cureus | 2023 | 38222201 | PubTator, text mining | PubMed |
| Mapping current trends and hotspots in myasthenia gravis from 2003 to 2022: a bibliometric analysis. | Front Neurol | 2023 | 38213833 | PubTator, text mining | PubMed |
| Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis. | Int J Mol Sci | 2023 | 38203616 | PubTator, text mining | PubMed |
| Cannabinoids, Endocannabinoids, and Synthetic Cannabimimetic Molecules in Neuromuscular Disorders. | Int J Mol Sci | 2023 | 38203407 | PubTator, text mining | PubMed |
| The Incidence of Myasthenia Gravis in the Province of Ferrara, Italy, in the Period of 2008-2022: An Update on a 40-Year Observation and the Influence of the COVID-19 Pandemic. | J Clin Med | 2023 | 38202243 | PubTator, text mining | PubMed |
| Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapy. | medRxiv | 2023 | 38196603 | PubTator, text mining | PubMed |
| Effectiveness of early glucocorticoids in myasthenia gravis: a retrospective cohort study. | Front Neurol | 2023 | 38187148 | PubTator, text mining | PubMed |
| Evidence for genetic causal relationships between gut microbiome, metabolites, and myasthenia gravis: a bidirectional Mendelian randomization study. | Front Immunol | 2023 | 38179043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=16